What Docuvera does

Docuvera, operating as Docuvera Software Corporation, is a private Seattle-based software company that provides an AI-powered structured content authoring platform purpose-built for regulated life sciences documentation. The company serves enterprise and mid-sized pharmaceutical organizations globally, with offices in Seattle (North America), Wellington and Palmerston North (APAC), and Gütersloh (Europe), and a stated customer footprint across the U.S., EU, APAC, and LATAM. Named reference customers include Eli Lilly and Boehringer Ingelheim.

The platform is built on a modular, component-based content architecture with metadata tagging, component-level version control, audit history, and a governance layer providing role-based access control, GxP-aligned workflow orchestration, and change propagation across linked documents. It is delivered as validated SaaS hosted on SOC 2 Type 2 and ISO 27001 certified infrastructure, with alignment to 21 CFR Part 11 and EU Annex 11. The product portfolio spans a core platform and seven specialized modules covering Global Labeling, Clinical, Chemistry Manufacturing & Controls, Medical Information, Pharmacovigilance & Safety, Quality & SOPs, and a Governance Layer, supplemented by an AI Co-writer that uses retrieval-augmented generation with human-in-the-loop controls. The platform integrates with LIMS, MES, safety and clinical systems, RIM, translation management systems, and standards including HL7 FHIR, CDISC, USDM, ISO IDMP, and TransCelerate DDF, and publishes outputs in eCTD, PDF, XML, SPL, ePI, Word, and HTML formats. Documented customer outcomes include up to 80% content reuse across labeling outputs, 65% component reuse at Eli Lilly in the first year, 30–50% reduction in change implementation cycle time, 30–40% reduction in review cycle times, and 60% fewer downstream publishing errors.

Docuvera monetizes via a recurring SaaS subscription model, sold through direct enterprise sales engagement, demo requests, and website contact forms. Pricing is not publicly disclosed and is negotiated on a quote basis. The company employs 51–100 people and is privately held with no disclosed parent company, venture capital funding, or ownership changes identified. Distribution is direct, with no disclosed reseller or marketplace channels, and go-to-market is reinforced by content marketing, industry conference participation, and thought-leadership assets aimed at regulatory, clinical, and labeling functions within pharmaceutical companies.

Name

Docuvera

Legal name

Docuvera Software Corporation

Website

https://docuvera.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Docuvera is a private Seattle-based SaaS company that provides an AI-powered, component-based structured content authoring platform for regulated life sciences documentation, serving enterprise and mid-sized pharmaceutical companies with modules covering labeling, clinical, CMC, medical information, pharmacovigilance, quality, and governance workflows.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Content Management Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Electronic Data Capture (EDC) Platforms (HLACAOAA)

Keywords

• Structured content authoring
• Pharmaceutical documentation
• Regulatory content management
• Life sciences compliance software
• Pharma labeling platform

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Subscription Platform: Docuvera operates as a validated SaaS solution providing access to their structured content authoring platform on a subscription basis. The platform is hosted on SOC 2 Type 2 certified infrastructure, indicating a cloud-hosted delivery model with recurring subscription fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Docuvera is an AI-powered structured content authoring SaaS platform purpose-built for regulated life sciences documentation. The platform replaces document-first workflows with modular, version-controlled content components that can be authored once and reused across teams, document types, and global markets, supporting use cases spanning global labeling, clinical, CMC, medical information, pharmacovigilance, and quality/SOP documentation. It is hosted on SOC 2 Type 2 certified infrastructure and certified to ISO 27001, with built-in support for 21 CFR Part 11 and Annex 11 compliance.

Product overview

Docuvera is a unified AI-powered structured content authoring platform purpose-built for regulated life sciences content, comprising a core platform with integrated modules for specific use cases. The platform architecture centers on the Docuvera Platform as the foundation, which enables modular, version-controlled content components that can be authored once and reused across multiple outputs. The solution portfolio includes specialized modules: Global Labeling for CCDS, SmPC, USPI, and ePI management; Clinical for trial documentation; Chemistry, Manufacturing & Controls (CMC) for Module 3 content; Medical Information for scientific response management; Pharmacovigilance & Safety for safety reporting; and Quality & SOPs for quality documentation. A Governance Layer provides enterprise-wide controls including component-level version control, RBAC, and change propagation. The AI Co-writer feature enhances the platform with generative AI capabilities for accelerated drafting and reuse recommendations. All modules share the same underlying platform, content repository, and governance framework, enabling true cross-functional reuse—content created in one module can be surfaced and reused in others.

Differentiator

Problem solved

Functional benefit

Brands

• Cormeo: A sub-brand or platform mentioned on the company's About page, operating under Docuvera's umbrella.

Products and services

• Docuvera Platform AI-powered structured content authoring platform purpose-built for regulated life sciences content. Replaces scattered files with modular, traceable, and compliant content components that can be created once and reused across teams, document types, and global markets. For pharmaceutical and life sciences regulatory, clinical, CMC, medical information, safety, and quality teams.
• Global Labeling Structured content solution for global pharmaceutical labeling including CCDS, SmPC, USPI, and ePI, with support for local and global needs, variant control, and multiformat publishing. For global and local regulatory labeling teams in pharmaceutical companies.
• Clinical Clinical trial documentation solution enabling standardization of protocols, CSRs, and investigator brochures to streamline workflows, reduce rework, and enable modular collaboration across clinical teams. For clinical operations, medical writing, and regulatory teams.
• Chemistry, Manufacturing, & Controls (CMC) CMC documentation solution enabling modular authoring and content reuse for Module 3 and site-specific variations, with support for upstream data integration from LIMS, MES, and manufacturing systems. For CMC and regulatory teams managing Module 3 content, product specifications, and variation submissions.
• Medical Information Medical information solution for managing modular scientific response content with traceability across formats, regions, and delivery channels including digital endpoints, AEM-powered websites, chatbots, and field medical tools. For medical information and medical affairs teams.
• Pharmacovigilance & Safety Pharmacovigilance and safety documentation solution supporting modular authoring for DSURs, PSURs, RMPs, signal evaluation documentation, investigator brochures, and clinical narratives with version control and traceability. For safety writing and pharmacovigilance teams.
• Quality & SOPs Quality documentation and SOP management solution replacing static SOPs with structured, version-controlled content components governed by built-in audit trails and change management workflows. For quality teams managing SOPs, work instructions, and training documents under GxP compliance.
• Multi Use Case Structured Content Cross-functional solution enabling modular content reuse across Regulatory, Medical, Clinical, and CMC use cases with shared structured repository, upstream system integration, and unified governance applied across all functions.

Quantifiable outcome

• Up to 80% content reuse across CCDS, SmPC, USPI, and ePI outputs
• +7 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability6 records

Feature6 records

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ArisGlobal: ArisGlobal's LifeSphere RIM, LifeSphere Quality, and LifeSphere Safety products are direct competitors in pharma regulatory information management and structured content for labeling, submissions, and safety reporting.
• LORENZ Life Sciences: LORENZ Life Sciences provides regulatory content management and e-submission software for pharma (docuBridge, LORENZ eCTD), competing with Docuvera in structured authoring and submission publishing workflows.
• Sparta Systems (a Honeywell company): Sparta's TrackWise quality management platform competes with Docuvera's Quality & SOPs and governance modules for GxP-compliant quality documentation in pharmaceutical manufacturing and operations.
• Veeva Systems: Veeva's Vault RIM, Vault QualityDocs, and Vault Safety suites compete most directly with Docuvera's regulated content authoring platform, targeting the same pharmaceutical regulatory, quality, and safety functions with a broader enterprise cloud platform.
• MasterControl: MasterControl's Quality Management System and document/SOP management platform directly competes with Docuvera's Quality & SOPs module in GxP-regulated life sciences quality documentation.
• EXTEDO: EXTEDO specializes in structured content authoring and regulatory submission management (eCTD, RIM) for life sciences, overlapping directly with Docuvera's global labeling, CMC, and submission-ready content modules.
• Acolad (formerly Amplexor Life Sciences): Acolad/Amplexor's life sciences content management and regulatory submission solutions compete with Docuvera in pharma documentation, multilingual content, and submission publishing.
• DXC Technology (formerly CSC Life Sciences): DXC's life sciences regulatory solutions, inherited from CSC, include regulatory information management and submission services that overlap with Docuvera's structured content and submission publishing offerings.

Broad incumbents

• IQVIA: IQVIA's regulatory technology and safety offerings (formerly part of Q² Solutions and broader IQVIA Tech) provide broader, incumbent-scale alternatives to Docuvera's regulatory content and submission solutions.
• Oracle Health Sciences: Oracle's Clinical One, Argus Safety, and Health Sciences Data Management offerings are broader enterprise alternatives in pharma regulatory and clinical operations where Docuvera competes.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/docuvera

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Docuvera